[DOG (German Ophthalmological Society): retinopathy of prematurity best possible treatment. Antibody therapy - only advisable in certain cases].
Deutsche Ophthalmologische Gesellschaft, Stuttgart.
Anna Julia
AJ
Voormann
D060433:Administration, Ophthalmic; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000068258:Bevacizumab; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D017075:Laser Coagulation; D056687:Off-Label Use; D011247:Pregnancy; D012178:Retinopathy of Prematurity / Q000451:nursing* / Q000628:therapy*; D012307:Risk Factors; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab